The DOI matches its Crossref record.
Oxysterols induce interleukin‐1β production in human macrophages
Abstract
Abstract Background Oxysterols are biologically active molecules generated during the oxidation of low‐density lipoprotein or formed enzymatically in vivo. In the atherosclerotic plaque newly recruited macrophages may be exposed to oxysterols present in the plaque. How these oxysterols affect the expression and secretion of inflammatory cytokines such as interleukin‐1β (IL‐1β) in macrophages is not known. Therefore the aim of the present study was to investigate how oxysterols regulate the expression and secretion of IL‐1β in human monocyte‐derived macrophages. Methods The IL‐1β messenger RNA (mRNA) expression was analysed by reverse transcription‐polymerase chain reaction, and the IL‐1β protein secretion was measured by enzyme‐linked immunosorbent assay. Results A significant, dose‐dependent increase in the secretion of IL‐1β was given by 25‐hydroxycholesterol without the addition of lipopolysaccharide (LPS). At a concentration of 2·5 µg mL−1 this increase was similar to that obtained by endotoxin (LPS, 1 µg mL−1). A transient increase in IL‐1β mRNA expression was found in macrophages incubated with 25‐hydroxycholesterol compared with untreated controls. In addition, 25‐hydroxycholesterol dramatically increased the IL‐1β secretion induced by LPS. At a concentration of 5 µg mL−1 of 25‐hydroxycholesterol the LPS‐induced IL‐1β secretion was increased by about 25‐fold. A similar tendency, but not so consistent, was found for 27‐hydroxycholesterol. Conclusions Our results show that oxysterols, and 25‐hydroxycholesterol in particular, may modulate the inflammatory response in human macrophages. Consequently the presence of oxysterols in atherosclerotic tissue may dramatically influence the effect of inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rosklint and colleagues demonstrated that 25-HC increased IL-1β mRNA expression and secretion following LPS challenge in human monocyte-derived macrophages.
“Rosklint and colleagues [79] first demonstrated that 25-HC, even at very low concentrations, increased IL-1β mRNA expression and secretion following LPS challenge in human monocyte-derived macrophages”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [79]
The effects of 25-HC in potentiating IL-1β/α expression/secretion in microglia are also observed at much lower concentrations (e.g., 1 μg/ml).
“the effects of 25-HC in potentiating IL-1β/α expression/secretion in microglia are also observed at much lower concentrations (e.g., 1 μg/ml see Fig. 5d)”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [79]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 43
- 10.1056/NEJM199901143400207 · DOI · Paper page
- Moyer CF, 1991, Synthesis of IL‐1 alpha and IL‐1 beta by arterial cells in atherosclerosis, Am J Pathol, 138, 951
- Tipping PG, 1993, Production of tumor necrosis factor and interleukin‐1 by macrophages from human atheromatous plaques, Am J Pathol, 142, 1721
- Kuby J., 1994, Immunology
- 10.1182/blood.V87.6.2095.bloodjournal8762095 · DOI · Paper page
- 10.1016/0021-9150(94)05503-B · DOI
- 10.1159/000023992 · DOI
- 10.1016/0021-9150(93)90026-Q · DOI
- 10.1172/JCI118476 · DOI
- Ito A, 1996, The role of fibroblast growth factor‐2 in the vascular effects of interleukin‐1 beta in porcine coronary arteries in vivo, Cardiovasc Res, 32, 570
- Libby P, 1992, A cascade model for restenosis. A special case of atherosclerosis progression, Circulation, 86, III47
- 10.1038/312458a0 · DOI
- 10.1073/pnas.81.24.7907 · DOI
- Sahasrabuddhe CG, 1985, Intracellular human IL‐1: a precursor for the secreted monokine, Lymphokine Res, 4, 205
- 10.1084/jem.162.3.790 · DOI
- 10.1126/science.1373520 · DOI
- 10.1038/356768a0 · DOI
- 10.1016/S0021-9258(19)76559-4 · DOI
- Heinecke JW., 1998, Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density l ipoprotein hypothesis, Atherosclerosis, 141, 1, 10.1016/S0021-9150(98)00173-7 · DOI
- 10.1016/0009-3084(87)90046-6 · DOI
- 10.1006/abio.1995.1110 · DOI
- 10.1016/0005-2760(94)00247-V · DOI
- 10.1016/0005-2760(96)00052-5 · DOI
- 10.1172/JCI118436 · DOI
- 10.1016/S0021-9150(98)00196-8 · DOI
- 10.1111/j.1365-3083.1976.tb03851.x · DOI
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- 10.3109/00365517409082499 · DOI
- 10.1161/01.ATV.17.2.317 · DOI
- 10.1016/S0090-6980(98)00024-0 · DOI
- 10.1172/JCI118780 · DOI
- 10.1016/S0014-5793(97)01473-7 · DOI
- 10.1016/0022-4731(81)90238-7 · DOI
- 10.1016/S0005-2760(96)00152-X · DOI
- 10.1073/pnas.91.18.8592 · DOI
- 10.1016/S0021-9150(99)00463-3 · DOI · Paper page
- 10.1002/j.1460-2075.1990.tb08268.x · DOI
- 10.1073/pnas.90.15.7245 · DOI
- 10.1084/jem.182.5.1447 · DOI
- 10.1038/sj.cdd.4400598 · DOI
- 10.1038/sj.cdd.4400433 · DOI
- 10.1126/science.7535475 · DOI
- 10.1016/0092-8674(95)90490-5 · DOI
Cited by
Sorted by citations
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Thiazolidinediones improve β-cell function in type 2 diabetic patients
Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00551.2006 · Cited by 200
25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner
Wong, M. Y., Lewis, M., Doherty, J. J., Shi, Y., Cashikar, A. G., Amelianchik, A., Tymchuk, S., Sullivan, P. M., Qian, M., Covey, D. F., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01869-3 · Cited by 121
Abdul-Ghani, M. A., Matsuda, M., Jani, R., Jenkinson, C. P., Coletta, D. K., Kaku, K., & DeFronzo, R. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00674.2007 · Cited by 91
Metadata
- Authors
- Rosklint, T., Ohlsson, B. G., Wiklund, O., Norén, K., & Hultén, L. M.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 32
- Issue
- 1
- Pages
- 35-42
- ISSN
- 0014-2972
- 1365-2362
- Cited by
- 63
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review